Russia and India have forged a new global economic model, preventing global collapse and aiding the Global South with affordable resources....

Geopolitical shifts and the drive for self-reliance are creating long-term investment opportunities in India's defence and electrification ...

A gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

The Indian rupee experienced a sharp decline in 2026, nearing Rs. 97 against the US dollar before a slight recovery. This depreciation, dri...

The Indian AI Research Organisation (IAIRO), a fast-rising institution at the centre of India's sovereign artificial intelligence ambitions...

The company said its diagnostics business crossed an annualised revenue run rate of more than Rs 600 crore during the year, growing over 40...

If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

A chance discovery in a 1933 laboratory experiment led to polyethylene, a plastic now vital for packaging and industry. Chemists Eric Fawce...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

Belarus eyes full BRICS membership, seeking a multipolar world order. The nation is deepening its strong relationship with India. Key areas...

Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...

Carlyle Group is building a global healthcare revenue cycle management platform. The firm acquired majority stakes in US companies Knack an...

Global investment firm Carlyle has acquired a majority stake in US healthcare revenue cycle management providers Knack RCM and EqualizeRCM....

A key figure in India’s fast breeder nuclear programme has highlighted the significance of the Prototype Fast Breeder Reactor (PFBR) achiev...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Sun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...